PharmaHub · Therapeutics · Global

Diabetes Care: Market Size & Forecast 2026

The global Diabetes Care market encompasses products and services for managing diabetes, including glucose monitors, insulin pumps, continuous glucose monitoring systems, insulin pens, and associated software platforms. Valued at approximately $41.06 billion in 2025, the market is expanding at roughly 10.88% annually, driven by rising diabetes prevalence, aging populations, and technological advances in connected health devices. Growth is further supported by increasing healthcare spending in emerging economies and a shift toward minimally invasive, patient-centric care models.

Market size · 2025
$41.1 billion
CAGR · 2025–2030
10.88%
Forecast · 2030
$68.8 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $41.1bn2030 est: $68.8bn
Read the full Diabetes Care report →

Market Overview

The Diabetes Care market covers a broad array of medical devices, pharmaceuticals, digital platforms, and services designed to help people with diabetes monitor their condition and administer treatment. While some industry reports focus narrowly on devices, estimating the devices segment alone at between roughly $34 billion and $46 billion in 2025, the broader care market, inclusive of therapeutics and digital services, is estimated near $41 billion for that year. Rising global obesity rates, sedentary lifestyles, and aging demographics continue to expand the patient population, creating sustained demand across both developed and developing regions.

  • Market size estimates vary by research firm and scope, with device-only segments ranging from roughly $34 billion to $46 billion in 2025
  • The broader Diabetes Care market, including therapeutics and digital health, is estimated at approximately $41.06 billion in 2025
  • Chronic disease management and integrated care platforms are increasingly central to how providers and payers address diabetes at scale

Growth Drivers

The primary force behind market expansion is the rising global prevalence of diabetes, with the International Diabetes Federation estimating hundreds of millions of adults living with the condition worldwide. Advances in continuous glucose monitoring, smart insulin delivery systems, and AI-driven analytics have made diabetes management more precise and less burdensome for patients. Additionally, expanding insurance coverage for diabetes devices and growing patient awareness are accelerating adoption across both established and emerging markets.

  • Over 537 million adults worldwide were living with diabetes as of 2021, with prevalence expected to rise significantly by 2030
  • Technological innovations in CGM, closed-loop insulin pumps, and digital therapeutics are driving premium product demand
  • Government initiatives and favorable reimbursement policies in markets such as the United States, Europe, and parts of Asia are supporting market access
Want a deeper cut on Diabetes Care? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is typically segmented by product type into blood glucose monitoring devices (including self-monitoring and continuous systems), insulin delivery devices (pens, pumps, and jet injectors), and software-driven digital platforms. North America commands the largest regional share, fueled by high diabetes prevalence, advanced healthcare infrastructure, and strong reimbursement. Asia-Pacific is the fastest-growing region, driven by rising diagnosis rates in China and India, improving healthcare access, and increasing adoption of connected devices.

  • North America holds the largest regional share, while Asia-Pacific is the fastest-growing market due to rising prevalence and expanding healthcare access
  • Blood glucose monitoring and insulin delivery devices together account for the majority of market revenue within the devices segment
  • Emerging markets in Latin America and the Middle East are gradually contributing more as local manufacturing and distribution improve

Trends and Outlook

What are the recent trends and outlook?

The market is moving toward more integrated, automated diabetes management solutions, including closed-loop systems that combine CGM and insulin pumps with algorithmic dosing. Digital therapeutics and telehealth platforms are also gaining regulatory acceptance, enabling remote monitoring and virtual coaching for patients. Over the coming years, partnerships between device makers and software developers, as well as the growing use of real-world data to refine treatment algorithms, are expected to reshape how diabetes care is delivered globally.

  • Closed-loop automated insulin delivery systems and next-generation CGM wearables are among the most anticipated near-term innovations
  • Digital therapeutics and AI-powered care platforms are emerging as a significant adjunct to traditional hardware-based diabetes management
  • Long-term market projections vary widely by firm, but most anticipate multi-year double-digit percentage growth as prevalence rises and technology adoption deepens
Talk to a Claight analyst
Do you want to research Diabetes Care?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.